Qualitative study of the acceptability and feasibility of acceptance and commitment therapy for adolescents with chronic fatigue syndrome.
adolescent health
psychology
qualitative research
Journal
BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
04
2021
accepted:
17
07
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
epublish
Résumé
Paediatric chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is disabling and relatively common. Although evidenced-based treatments are available, at least 15% of children remain symptomatic after one year of treatment. Acceptance and commitment therapy (ACT) is an alternative therapy option; however, little is known about whether it is an acceptable treatment approach. Our aim was to find out if adolescents who remain symptomatic with CFS/ME after 12 months of treatment would find ACT acceptable, to inform a randomised controlled trial (RCT) of ACT. We recruited adolescents (diagnosed with CFS/ME; not recovered after one year of treatment; aged 11-17 years), their parent/carer and healthcare professionals (HCPs) from one specialist UK paediatric CFS/ME service. We conducted semi-structured interviews to explore barriers to recovery; views on current treatments; acceptability of ACT; and feasibility of an effectiveness RCT. Thematic analysis was used to identify patterns in data. Twelve adolescents, eleven parents and seven HCPs were interviewed. All participants thought ACT was acceptable. Participants identified reasons why ACT might be efficacious: pragmatism, acceptance and compassion are valued in chronic illness; values-focussed treatment provides motivation and direction; psychological and physical needs are addressed; normalising difficulties is a useful life-skill. Some adolescents preferred ACT to cognitive behavioural therapy as it encouraged accepting (rather than challenging) thoughts. Most adolescents would consent to an RCT of ACT but a barrier to recruitment was reluctance to randomisation. All HCPs deemed ACT feasible to deliver. Some were concerned patients might confuse 'acceptance' with 'giving up' and called for clear explanations. All participants thought the timing of ACT should be individualised. All adolescents with CFS/ME, parents and HCPs thought ACT was acceptable, and most adolescents were willing to try ACT. An RCT needs to solve issues around randomisation and timing of the intervention.
Sections du résumé
Background
Paediatric chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is disabling and relatively common. Although evidenced-based treatments are available, at least 15% of children remain symptomatic after one year of treatment. Acceptance and commitment therapy (ACT) is an alternative therapy option; however, little is known about whether it is an acceptable treatment approach. Our aim was to find out if adolescents who remain symptomatic with CFS/ME after 12 months of treatment would find ACT acceptable, to inform a randomised controlled trial (RCT) of ACT.
Methods
We recruited adolescents (diagnosed with CFS/ME; not recovered after one year of treatment; aged 11-17 years), their parent/carer and healthcare professionals (HCPs) from one specialist UK paediatric CFS/ME service. We conducted semi-structured interviews to explore barriers to recovery; views on current treatments; acceptability of ACT; and feasibility of an effectiveness RCT. Thematic analysis was used to identify patterns in data.
Results
Twelve adolescents, eleven parents and seven HCPs were interviewed. All participants thought ACT was acceptable. Participants identified reasons why ACT might be efficacious: pragmatism, acceptance and compassion are valued in chronic illness; values-focussed treatment provides motivation and direction; psychological and physical needs are addressed; normalising difficulties is a useful life-skill. Some adolescents preferred ACT to cognitive behavioural therapy as it encouraged accepting (rather than challenging) thoughts. Most adolescents would consent to an RCT of ACT but a barrier to recruitment was reluctance to randomisation. All HCPs deemed ACT feasible to deliver. Some were concerned patients might confuse 'acceptance' with 'giving up' and called for clear explanations. All participants thought the timing of ACT should be individualised.
Conclusions
All adolescents with CFS/ME, parents and HCPs thought ACT was acceptable, and most adolescents were willing to try ACT. An RCT needs to solve issues around randomisation and timing of the intervention.
Identifiants
pubmed: 34660913
doi: 10.1136/bmjpo-2021-001139
pii: bmjpo-2021-001139
pmc: PMC8488698
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Pagination
e001139Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: EC acts as a non-paid medical advisor for the Sussex and Kent ME society.
Références
BMJ Open. 2017 Jan 13;7(1):e012633
pubmed: 28087544
Pain. 2009 Feb;141(3):248-257
pubmed: 19108951
Psychosom Med. 2015 May;77(4):449-57
pubmed: 25768845
Children (Basel). 2017 Jan 30;4(2):
pubmed: 28146108
BMC Health Serv Res. 2017 Jun 2;17(1):384
pubmed: 28576141
J Psychosom Res. 2016 Sep;88:42-7
pubmed: 27521652
Behav Anal. 2009 Spring;32(1):85-103
pubmed: 22478515
J Psychosom Res. 2011 Dec;71(6):411-5
pubmed: 22118384
Arch Dis Child. 2013 Jun;98(6):425-8
pubmed: 23619200
J Pediatr Psychol. 2013 Jan-Feb;38(1):72-81
pubmed: 23071352
J Psychosom Res. 2006 Nov;61(5):595-9
pubmed: 17084136
J Transl Med. 2020 Feb 24;18(1):100
pubmed: 32093722
Clin Psychol Rev. 2016 Jun;46:46-58
pubmed: 27176925
Lancet. 2012 Apr 14;379(9824):1412-8
pubmed: 22385683
BMC Psychiatry. 2020 Sep 21;20(1):457
pubmed: 32957944
Soc Sci Med. 2008 Jan;66(2):315-26
pubmed: 17961894
PLoS One. 2015 Jul 06;10(7):e0132421
pubmed: 26147503
Pediatrics. 2001 May;107(5):994-8
pubmed: 11331676
BMJ Open. 2011 Dec 12;1(2):e000252
pubmed: 22155938
J Psychosom Res. 2013 May;74(5):367-72
pubmed: 23597322